Cargando…

Randomized trial of neoadjuvant vaccination with tumor-cell lysate induces T cell response in low-grade gliomas

BACKGROUND: Long-term prognosis of WHO grade II low-grade gliomas (LGGs) is poor, with a high risk of recurrence and malignant transformation into high-grade gliomas. Given the relatively intact immune system of patients with LGGs and the slow tumor growth rate, vaccines are an attractive treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogino, Hirokazu, Taylor, Jennie W., Nejo, Takahide, Gibson, David, Watchmaker, Payal B., Okada, Kaori, Saijo, Atsuro, Tedesco, Meghan R., Shai, Anny, Wong, Cynthia M., Rabbitt, Jane E., Olin, Michael R., Moertel, Christopher L., Nishioka, Yasuhiko, Salazar, Andres M., Molinaro, Annette M., Phillips, Joanna J., Butowski, Nicholas A., Clarke, Jennifer L., Oberheim Bush, Nancy Ann, Hervey-Jumper, Shawn L., Theodosopoulos, Philip, Chang, Susan M., Berger, Mitchel S., Okada, Hideho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Clinical Investigation 2022
Materias:	Clinical Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803342/ https://www.ncbi.nlm.nih.gov/pubmed/34882581 http://dx.doi.org/10.1172/JCI151239

Ejemplares similares

IMMU-23. A NOVEL MASS CYTOMETRY-BASED MULTI-PARAMETER CHARACTERIZATION OF NEOANTIGEN-REACTIVE CD8+ T-CELLS IN PATIENTS PARTICIPATING IN PNOC007 H3.3K27M PEPTIDE VACCINE CLINICAL TRIAL
por: Taitt, Jared, et al.
Publicado: (2020)

IMMU-31. PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2+ H3.3K27M DIFFUSE MIDLINE GLIOMAS (DMG)
por: Mueller, Sabine, et al.
Publicado: (2020)

Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults
por: Schulte, Jessica D, et al.
Publicado: (2020)

IMMU-14. SynNotch chimeric antigen receptor (CAR) T-cells as a potential treatment for diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG)
por: Ferrerosa, Lauren, et al.
Publicado: (2022)

Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect
por: Gibson, David, et al.
Publicado: (2023)

The evolution of alternative splicing in glioblastoma under therapy
por: Wang, Lin, et al.
Publicado: (2021)

Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma
por: Olin, Michael R., et al.
Publicado: (2019)

Prospective genomically guided identification of “early/evolving” and “undersampled” IDH-wildtype glioblastoma leads to improved clinical outcomes
por: Zhang, Yalan, et al.
Publicado: (2022)

Involvement of White Matter Language Tracts in Glioma: Clinical Implications, Operative Management, and Functional Recovery After Injury
por: Aabedi, Alexander A., et al.
Publicado: (2022)

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy
por: Moertel, Christopher L, et al.
Publicado: (2014)

SURG-11. Surgery for control of brain metastases after prior checkpoint inhibitor immunotherapy: a single-center series
por: Morshed, Ramin, et al.
Publicado: (2021)

Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery
por: De Witt Hamer, Philip C, et al.
Publicado: (2021)

In Reply: Functional Outcomes and Health-Related Quality of Life Following Glioma Surgery
por: De Witt Hamer, Philip C, et al.
Publicado: (2021)

Reducing complication rates for repeat craniotomies in glioma patients: a single-surgeon experience and comparison with the literature
por: Morshed, Ramin A., et al.
Publicado: (2021)

Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma
por: Chuntova, Pavlina, et al.
Publicado: (2022)

A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma
por: Bush, Nancy Ann Oberheim, et al.
Publicado: (2021)

NGMA-6. Quantitative MGMT Promoter Methylation Index Indicates Non-Linear, Prognostic Effect in Glioblastoma
por: Gibson, David, et al.
Publicado: (2021)

Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis
por: Zhang, John J Y, et al.
Publicado: (2020)

Detection of glioma infiltration at the tumor margin using quantitative stimulated Raman scattering histology
por: Pekmezci, Melike, et al.
Publicado: (2021)

LOCL-06 SUPERVISED MACHINE LEARNING IDENTIFIES RISK FACTORS ASSOCIATED WITH LEPTOMENINGEAL DISEASE AFTER SURGICAL RESECTION OF BRAIN METASTASES
por: Morshed, Ramin, et al.
Publicado: (2022)

Sarcopenia Diagnosed Using Masseter Muscle Diameter as a Survival Correlate in Elderly Patients with Glioblastoma
por: Morshed, Ramin A., et al.
Publicado: (2022)

Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment
por: Müller, Sören, et al.
Publicado: (2017)

A lysate proteome engineering strategy for enhancing cell-free metabolite production()
por: Garcia, David C., et al.
Publicado: (2021)

Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma
por: Shin, Jaehoon, et al.
Publicado: (2023)

CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases
por: Morshed, Ramin A, et al.
Publicado: (2023)

5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches
por: Kiesel, Barbara, et al.
Publicado: (2021)

Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
por: Moertel, Christopher, et al.
Publicado: (2013)

TRLS-09. USE OF A PAN-PEPTIDE CHECKPOINT INHIBITOR IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS
por: Moertel, Christopher, et al.
Publicado: (2023)

Current Advances in Immunotherapy for Glioblastoma
por: Mende, Abigail L., et al.
Publicado: (2021)

Arterial Calcification on Wrist Radiographs May Suggest Need for Evaluation of Atherosclerosis in Asymptomatic Individuals
por: Watchmaker, Lauren E., et al.
Publicado: (2019)

Herpes Zoster: Experiments with Tissue Lysate as a Therapeutic Agent
por: Maplestone, P. A., et al.
Publicado: (1938)

Editorial: Quality of care of glioma patients
por: Forster, Marie-Therese, et al.
Publicado: (2022)

Corrigendum: Editorial: Quality of care of glioma patients
por: Forster, Marie-Therese, et al.
Publicado: (2022)

Rewiring cell-free metabolic flux in E. coli lysates using a block—push—pull approach
por: Dinglasan, Jaime Lorenzo N, et al.
Publicado: (2023)

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
por: Chheda, Zinal S., et al.
Publicado: (2018)

Glioma immunoediting, a driver of tumor evolution, and the next battle for immunotherapy
por: Sonabend, Adam M., et al.
Publicado: (2021)

Diversity in Neurosurgery
por: Kim, Eliana E., et al.
Publicado: (2021)

Chitosan Reinforced with Kenaf Nanocrystalline Cellulose as an Effective Carrier for the Delivery of Platelet Lysate in the Acceleration of Wound Healing
por: Bhatnagar, Payal, et al.
Publicado: (2021)

IMMU-10. USE OF A SINGLE PEPTIDE CHECKPOINT INHIBITOR FOR TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS
por: Moertel, Christopher, et al.
Publicado: (2021)

IFN-γ- and IL-17-producing CD8(+) T (Tc17-1) cells in combination with poly-ICLC and peptide vaccine exhibit antiglioma activity
por: Ohkuri, Takayuki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j7f78uuasl7rodqht46uvrirnd